Fresenius Medical Care
920 Winter Street
About Fresenius Medical Care
Fresenius Medical Care North America (FMCNA) is proud that our unwavering commitment to our patients has made us the global leader in dialysis healthcare. Our caring professionals touch the lives of over 160,000 patients and their families, combining innovative care with profound personal connections. We're the largest provider of renal care products and services in the nation, including state-of-the-art dialysis machines, dialyzers and pharmaceuticals. We're also home to the country's largest renal specialty laboratories. Every day, our professionals collaborate, challenge one another and ultimately make groundbreaking discoveries that change patients' lives for the better. FMCNA's dialysis care services include hemodialysis, home dialysis and transplant support services, and in-center services to provide our patients with unsurpassed personalized care.
The FMCNA team comprises over 55,000 dedicated employees in North America, all of whom are focused on a singular goal: delivering the highest-quality care to help patients with renal disease live the most fulfilling, rewarding lives possible.
Our facility in Concord CA is our exclusive site for research, development, manufacturing, warehousing and technical services for our durable medical device products including our hemodialysis machine (2008® as well as accessories and upgrade kits) and three peritoneal dialysis systems (Liberty®, Newton IQ® and Freedom Cycler® systems) currently in commercial production. The site is our first and oldest site in North America and was opened in 1986. The site was located in Walnut Creek CA for many years however in 2013 due to the need for significantly more space we relocated to a much larger facility in Concord CA investing in the site’s long-term future. All of the dialysis products used in North America are produced in North America.
Each of the employees working at our Concord plant has a profound commitment to the quality of the products we produce which directly ties into the quality of our patient care. Some faces have been with us since 1986 while others are new as we have grown every year since North American operations began. We are thrilled to have some additional products moving forward through development that will give our patients another treatment option.
147 articles with Fresenius Medical Care
Fresenius Medical Care Launches My Reason® Campaign to Enroll Patients in Groundbreaking Renal-focused Genomic Registry
Fresenius Medical Care announced today that the company's Global Medical Office has launched the My Reason® campaign to promote patient enrollment in the company's kidney-focused genomics registry which was first introduced last year.
Fresenius Medical Care Appoints Dr. Amaka Eneanya as Head of Strategy and Operations for Company's Global Medical Office
Fresenius Medical Care announced today the appointment of noted clinical researcher and nephrologist Nwamaka (Amaka) Eneanya, MD as Head of Strategy and Operations for the company's Global Medical Office.
Fresenius Medical Care North America Partners with 1,000+ Nephrology Providers for New Kidney Care Payment Models
Fresenius Medical Care North America announced today partnerships with more than 1,000 nephrology providers as part of the new Kidney Care Choice Payment Models.
Fresenius Medical Care increases investment in Humacyte, accompanies human acellular vessel developer's stock market launch
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, is investing an additional USD 25 million in the U.S. medical company Humacyte, Inc.
The combined company out of the Humacyte SPAC will be called Humacyte and is expected to trade shares of common stock and warrants on the Nasdaq Global Select Market.
Fresenius Medical Care North America and Cigna Expand Efforts to Help People Living with Kidney Failure
Fresenius Medical Care North America and Cigna announce an expansion of their national effort to improve health outcomes and lower the cost of care for people living with kidney failure, or end stage renal disease.
Humacyte, Inc. announces the expansion of the strategic collaboration between Fresenius Medical Care.
Fresenius Medical Care North America's Renal Therapies Group introduces the Kinexus™ Therapy Management Platform, a new connected health platform for home dialysis that supports the management of a patient's peritoneal dialysis therapy on the Liberty® Select cycler.
Fresenius Medical Care's Frenova enrolls patients in initiative to build world's largest genomic registry targeting kidney disease
Fresenius Medical Care, the world's leading provider of products and services for people with chronic kidney failure, announced that the company's Frenova division has enrolled the first participants in its new initiative to develop the largest renal-focused genomic registry in the world.
11/5/2020Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
ChemoCentryx and VFMCRP announce European Medicines Agency has accepted to review the Marketing Authorization Application for avacopan
Companies have completed the EU regulatory application for marketing approval of avacopan Regulatory submission based on positive data from the pivotal P hase-III ADVOCATE trial of avacopan
Fresenius Medical Care North America Announces Next Generation Solution Bags to Support Continued Home Dialysis Expansion
Fresenius Medical Care North America (FMCNA) , the nation's leading renal care company, celebrates National Dialysis Technician Recognition Week by announcing a new collaboration wit
Fresenius Medical Care North America Partners with Livongo to Empower People with Chronic Kidney Disease
Livongo to Provide Remote Monitoring, Connected Devices Powered by Advanced Data Science, and Personalized Coaching for People with Late-Stage CKD
The Power of Ideas and the people behind them: Fresenius Medical Care publishes 2020 Global Annual Medical Report
Fresenius Medical Care, the world's leading provider of products and services for people with chronic kidney failure, today announced publication of its 2020 Global Annual Medical Report. Titled "The Power of Ideas: Ingenuity, Optimism, and the Future of Global Healthcare," it advances the worldwide conversation about the contin
Fresenius Medical Care North America Celebrates Nephrology Nurses Week, Honoring Nurses' Selfless Commitment During Pandemic
Company Continues Support for The American Nephrology Nurses Association (ANNA) to Help Advance Practice of Nephrology Nursing Through Engagement and Education
Fresenius Medical Care North America Prepares Dialysis Patients as Hurricane Laura Approaches Gulf Coast
Fresenius Medical Care North America (FMCNA), the nation's leading provider of dialysis products and services, has activated its national disaster response team to ensure continuity of care as Hur
Fresenius Medical Care Foundation Announces Grant to United Network for Organ Sharing to Improve Organ Transportation, Tracking, and Logistics
$106,000 Grant Supports Work to Predict Organ Travel Time and Pilot Real-Time Tracking
Funding Will Support Delivery of Medically Tailored Meals to People Living with Kidney Failure and Those Struggling During COVID-19 Pandemic
Fresenius Medical Care North America Makes First Shipment of Acute Care Dialysis Solutions to U.S. Hospitals under FDA Emergency Use Authorization
Fresenius Medical Care North America's Renal Therapies Group, the leading provider of kidney care products, is preparing its first shipment of multiBic dialysate solutions for use in continuous renal replacement therapy.